Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
ALI HEALTH
00241
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 30.96%38.47M | ---- | -21.37%29.37M | ---- | -68.23%37.36M | ---- | 178.61%117.58M | ---- | -13.12%42.2M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 41.17%-8.43M | ---- | -3.27%-14.34M | ---- | 5.63%-13.88M | ---- | -7.51%-14.71M | ---- | -20.64%-13.68M |
| Dividend (income)- adjustment | ---- | -13.05%-2.69M | ---- | -54.29%-2.38M | ---- | -30.95%-1.54M | ---- | ---1.18M | ---- | ---- |
| Investment loss (gain) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -43.02%-1.91M | ---- | ---1.33M |
| Attributable subsidiary (profit) loss | ---- | -45.51%631K | ---- | 40.88%1.16M | ---- | 0.86%822K | ---- | -62.02%815K | ---- | 230.06%2.15M |
| Impairment and provisions: | ---- | -347.99%-11.16M | ---- | 736.62%4.5M | ---- | 128.77%538K | ---- | -1,000.00%-1.87M | ---- | 66.99%-170K |
| -Impairment of trade receivables (reversal) | ---- | -209.40%-4.92M | ---- | 736.62%4.5M | ---- | 128.77%538K | ---- | -1,000.00%-1.87M | ---- | 66.99%-170K |
| -Other impairments and provisions | ---- | ---6.24M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Revaluation surplus: | ---- | -469.78%-13.74M | ---- | 259.01%3.72M | ---- | 79.40%-2.34M | ---- | ---11.35M | ---- | ---- |
| -Fair value of investment properties (increase) | ---- | -71.37%732K | ---- | 153.55%2.56M | ---- | 55.98%-4.78M | ---- | ---10.85M | ---- | ---- |
| -Other fair value changes | ---- | -1,348.75%-14.47M | ---- | -52.46%1.16M | ---- | 588.58%2.44M | ---- | ---499K | ---- | ---- |
| Asset sale loss (gain): | ---- | 105.57%262K | ---- | -114.31%-4.7M | ---- | 90.75%-2.2M | ---- | -4,086.72%-23.72M | ---- | 1,365.96%595K |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---21.38M | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 105.57%262K | ---- | -114.31%-4.7M | ---- | 6.08%-2.2M | ---- | -492.77%-2.34M | ---- | 1,365.96%595K |
| Depreciation and amortization: | ---- | 3.31%105.76M | ---- | 8.52%102.37M | ---- | 0.90%94.33M | ---- | 10.29%93.49M | ---- | -23.76%84.76M |
| -Depreciation | ---- | -5.95%93.06M | ---- | 9.00%98.95M | ---- | 0.53%90.78M | ---- | 9.11%90.3M | ---- | -24.15%82.76M |
| -Amortization of intangible assets | ---- | 270.84%12.69M | ---- | -3.69%3.42M | ---- | 11.41%3.55M | ---- | 59.02%3.19M | ---- | -3.14%2.01M |
| Financial expense | ---- | 38.55%15.57M | ---- | 64.51%11.24M | ---- | 46.08%6.83M | ---- | -37.63%4.68M | ---- | -48.03%7.5M |
| Exchange Loss (gain) | ---- | -9.49%31.15M | ---- | 259.53%34.42M | ---- | -980.53%-21.57M | ---- | -23.77%2.45M | ---- | --3.21M |
| Special items | ---- | ---- | ---- | -99.09%141K | ---- | 507.16%15.43M | ---- | -72.75%2.54M | ---- | --9.33M |
| Operating profit before the change of operating capital | ---- | -5.85%155.82M | ---- | 45.44%165.5M | ---- | -31.79%113.79M | ---- | 23.98%166.83M | ---- | -16.23%134.57M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -95.35%1.79M | ---- | 174.53%38.46M | ---- | 31.92%-51.6M | ---- | -284.77%-75.79M | ---- | 0.03%41.02M |
| Accounts receivable (increase)decrease | ---- | -163.84%-47.12M | ---- | 21.49%-17.86M | ---- | -867.46%-22.75M | ---- | 92.34%-2.35M | ---- | -201.11%-30.7M |
| Accounts payable increase (decrease) | ---- | 29.49%-20.7M | ---- | -447.97%-29.35M | ---- | -58.36%8.44M | ---- | -28.01%20.26M | ---- | 713.68%28.14M |
| Special items for working capital changes | ---- | --7.44M | ---- | ---- | ---- | -1,707.79%-20.02M | ---- | 133.91%1.25M | ---- | ---3.67M |
| Cash from business operations | ---- | -37.97%97.23M | ---- | 462.61%156.75M | ---- | -74.72%27.86M | ---- | -34.93%110.19M | ---- | -28.08%169.35M |
| Other taxs | ---- | -45.02%-13.4M | ---- | 60.60%-9.24M | ---- | 15.49%-23.45M | ---- | -264.81%-27.75M | ---- | -12.28%-7.61M |
| Special items of business | 204.58%70.58M | ---- | -41.80%23.17M | ---- | 23.06%39.82M | ---- | -55.17%32.36M | ---- | -35.23%72.17M | ---- |
| Net cash from operations | 204.58%70.58M | -43.17%83.83M | -41.80%23.17M | 3,244.90%147.51M | 23.06%39.82M | -94.65%4.41M | -55.17%32.36M | -49.03%82.44M | -35.23%72.17M | -29.28%161.74M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | -41.17%8.43M | ---- | 3.27%14.34M | ---- | -5.55%13.88M | ---- | 5.71%14.7M | ---- | 24.82%13.9M |
| Dividend received - investment | -11.86%2.22M | 13.05%2.69M | 25.16%2.52M | 54.29%2.38M | 30.93%2.02M | 30.95%1.54M | 30.87%1.54M | --1.18M | --1.18M | ---- |
| Loan receivable (increase) decrease | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 64.14%2.21M | ---- | 139.44%1.35M |
| Sale of fixed assets | -27.26%4.87M | 1.82%6.08M | 4.35%6.69M | -7.19%5.97M | -75.19%6.42M | -12.32%6.44M | 5,263.90%25.85M | 119.83%7.34M | -69.36%482K | 407.45%3.34M |
| Purchase of fixed assets | 33.94%-63.04M | -59.93%-164.62M | -117.36%-95.43M | -4.00%-102.93M | 37.76%-43.9M | 12.22%-98.97M | -36.11%-70.54M | -57.24%-112.74M | -159.71%-51.82M | -159.27%-71.7M |
| Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --18.02M | ---- | ---- |
| Acquisition of subsidiaries | ---- | -207.05%-168.07M | ---168.06M | ---54.74M | ---- | ---- | ---- | ---84.45M | ---80.99M | ---- |
| Recovery of cash from investments | --3.62M | ---- | ---- | ---- | ---- | -99.40%79K | ---- | -81.65%13.18M | 683.97%45.33M | --71.8M |
| Cash on investment | ---- | ---- | ---- | ---- | ---- | 43.22%-9.97M | ---- | 75.08%-17.56M | -951.80%-46.42M | ---70.46M |
| Net cash from investment operations | 79.42%-52.33M | -133.72%-315.48M | -616.80%-254.28M | -55.14%-134.98M | 17.77%-35.47M | 44.98%-87M | 67.38%-43.14M | -205.40%-158.13M | -677.33%-132.24M | -168.65%-51.78M |
| Net cash before financing | 107.90%18.25M | -1,948.77%-231.65M | -5,420.07%-231.1M | 115.17%12.53M | 140.27%4.34M | -9.11%-82.59M | 82.04%-10.79M | -168.84%-75.69M | -163.63%-60.07M | -47.49%109.96M |
| Cash flow from financing activities | ||||||||||
| New borrowing | -74.52%54.61M | --175.36M | --214.29M | ---- | ---- | --225.85M | --220M | ---- | ---- | ---- |
| Refund | -54.91%-146.45M | -61.99%-64.8M | -372.68%-94.54M | 77.88%-40M | 86.57%-20M | -235.83%-180.8M | -451.25%-148.94M | -0.00%-53.84M | 0.00%-27.02M | 89.83%-53.84M |
| Interest paid - financing | 38.83%-5.31M | -40.87%-14.22M | -101.39%-8.68M | -110.40%-10.09M | -131.95%-4.31M | -59.18%-4.8M | ---1.86M | 50.63%-3.01M | ---- | 49.30%-6.1M |
| Dividends paid - financing | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 84.56%-975K | ---741K | -439.66%-6.31M |
| Absorb investment income | ---- | --6.14M | ---- | ---- | ---- | -93.25%2.9M | -89.93%1.33M | --42.89M | --13.18M | ---- |
| Other items of the financing business | ---- | -14,600.00%-13.92M | ---- | --96K | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash from financing operations | -188.71%-97.64M | 271.90%87.64M | 548.53%110.07M | -219.70%-50.98M | -134.94%-24.54M | 363.31%42.59M | 579.99%70.23M | 76.02%-16.18M | 46.92%-14.63M | 64.90%-67.46M |
| Effect of rate | -0.60%3.5M | 6.07%-15.22M | 206.43%3.52M | 77.28%-16.21M | 92.73%-3.31M | -990.86%-71.32M | -188.82%-45.52M | -76.89%8.01M | 73.00%-15.76M | 435.62%34.65M |
| Net Cash | 34.41%-79.39M | -274.54%-144.02M | -499.35%-121.04M | 3.88%-38.45M | -133.97%-20.2M | 56.46%-40M | 179.57%59.44M | -316.14%-91.87M | -211.76%-74.7M | 146.60%42.5M |
| Begining period cash | -23.61%515.16M | -7.50%674.4M | -7.50%674.4M | -13.25%729.06M | -13.25%729.06M | -9.07%840.38M | -9.07%840.38M | 9.11%924.25M | 9.11%924.25M | 0.82%847.09M |
| Cash at the end | -21.12%439.27M | -23.61%515.16M | -21.07%556.89M | -7.50%674.4M | -17.41%705.55M | -13.25%729.06M | 2.46%854.3M | -9.07%840.38M | -2.55%833.78M | 9.11%924.25M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Furimazer Certified Public Accountants Limited | -- | Furimazer Certified Public Accountants Limited | -- | Furimazer Certified Public Accountants Limited | -- | KPMG | -- | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.